NCT07015437 - A Recovery and Lifespan Study Using INTERCEPT Red Blood Cells Prepared Using the INTERCEPT Blood System for RBCs With AS-1 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 19, 2025

Primary Completion Date

July 30, 2026

Study Completion Date

October 15, 2026

Conditions

Healthy Subjects

Interventions

DEVICE

INTERCEPT Blood System for RBCs

RBCs treated with the INTERCEPT Blood System for RBCs

OTHER

Infusion of autologous radiolabeled RBCs

Subject will receive a single intravenous infusion of approximately 10 to 30 mL of autologous Day 35 51Cr radiolabeled RBCs and fresh 99mTc RBCs.

Trial Locations (2)

RECRUITING

American Red Cross Research Laboratory, Norfolk

NOT_YET_RECRUITING

Hoxworth Blood Center, Cincinnati